Staphylococcus aureus intramammary challenge in non-lactating mammary glands stimulated to rapidly grow and develop with estradiol and progesterone.

Intramammary infections (IMI) are prevalent in non-lactating dairy cattle and their occurrence during periods of significant mammary growth and development (i.e. pregnant heifers and dry cows) is believed to interfere with growth, development, and subsequent milk production. However, direct study of IMI impacts on non-lactating but developing mammary glands is lacking. The objectives of this study were to (1) define how IMI affected total and differential mammary secretion somatic cell counts in mammary glands stimulated to rapidly grow using estradiol and progesterone, and (2) characterize changes in mammary morphology in response to IMI. Mammary growth was stimulated in 19 non-pregnant, non-lactating cows and 2 quarters of each cow were subsequently infused with either saline (n = 19) or Staphylococcus aureus (n = 19). Mammary secretions were taken daily until mammary tissues were collected at either 5 or 10 days post-challenge. Staph. aureus quarter secretions yielded greater concentrations of somatic cells than saline quarters and contained a greater proportion of neutrophils. Staph. aureus mammary tissues exhibited higher degrees of immune cell infiltration in luminal and intralobular stroma compartments than saline quarters. Infected tissues also contained reduced areas of epithelium and tended to have greater amounts of intralobular stroma. Results indicate that IMI in non-lactating glands that were stimulated to grow, produced immune cell infiltration into mammary tissues and secretions, which was associated with changes in mammary tissue structure. The observed reduction of mammary epithelium indicates that IMI impair mammary development in rapidly growing mammary glands, which may reduce future reduced milk yields.

Mastitis and its impact on structure and function in the ruminant mammary gland.

It is a given in biology that structure and function go hand-in-hand. At the level of the mammary alveoli, copious milk production depends on the proliferation of mammary epithelial cells and the biochemical and structural differentiation of these cells after parturition. For example, data from quantitative structural studies demonstrate that differences in milk production between beef and dairy cows correspond with a relative failure of alveolar cell differentiation in cattle not specifically selected for milk yield. It is likely, but not proven, that production differences within or between dairy breeds are also determined by differences in the capacity of alveolar cells to differentiate or to maintain an adequate state of differentiation. These observations strongly support the belief that insults from mastitis that lead to losses in mammary function are directly related to disruption of alveolar cell integrity, sloughing of cells, induced apoptosis, and increased appearance of poorly-differentiated cells. Ironically, reduced milk production in cases of subclinical mastitis, is also associated with increases in milk somatic cell count. Thus the elevated neutrophil migration evoked to fight inflammation can inadvertently rendered alveolar epithelial cells non-secretory. A challenge to future researchers will be to devise mastitis treatments and therapies that prevent and/or repair damage to alveolar structure and maximize subsequent secretory cell differentiation.

Control of heifer mastitis: antimicrobial treatment-an overview.

Initial studies in Louisiana, USA to determine the prevalence of mastitis in breeding age dairy heifers demonstrated that intramammary infections (IMIs) were present in 97% of heifers and 75% of quarters. Most common isolates were Staphylococcus aureus, Staphylococcus hyicus, and Staphylococcus chromogenes; somatic cell counts (SCCs) ranged from 12.4 to 17.3 x 10(6)ml(-1). Histologic examination of Staph. aureus-infected quarters demonstrated significant reductions in alveolar epithelial and luminal areas, and increases in connective tissue and leukocytosis, illustrating limited secretory development and marked inflammation. A one-time infusion of various nonlactating cow antibiotic preparations into infected quarters during different stages of gestation but >45 days prepartum resulted in cure rates for Staph. aureus IMI of 67-100%. Mean SCC was 50% lower at calving for treated heifers, and milk yield over the first 2 months of lactation was 10% greater than that of untreated controls. Subsequent multiple herd studies, however, revealed that use of nonlactating cow therapy was beneficial only in herds exhibiting a high prevalence of heifer mastitis and not in low prevalence herds. Results of lactating cow antibiotic therapy infused 1-2 weeks prepartum demonstrated cure rates of 59-76% vs. 26-31.7% in untreated controls. In some studies, milk production during the first lactation in treated heifers was approximately 10% higher than untreated controls, and SCC were significantly lower; however, in other studies, prepartum treatment was successful in reducing prevalence of infection but had no effect on SCC or milk yield during the subsequent lactation. Thus, treatment of heifers is advantageous because the cure rate is much higher than during lactation, there is no milk loss, and risk of antibiotic residues minimal; however, successful therapy may not necessarily result in lowered SCC and increased milk production in all herds.

Efficacy of a Fatty Acid-Lactic Acid Postmilking Teat Germicide in Reducing Incidence of Bovine Mastitis.

The efficacy of a postmilking teat germicide containing Lauricidin®, and caprylic, capric, and lactic acids was evaluated against new udder infections caused by Staphylococcus aureus and Streptococcus agalactiae . The germicide was evaluated in two controlled infection trials using two dilutions of a concentrate. Active ingredients of the concentrate were 1% Lauricidin®, 5% caprylic/capric acids, and 6% lactic acid. The first dilution contained one part germicide to seven parts distilled water. New intramammary infections with Staphylococcus aureus and Streptococcus agalactiae were reduced 34.6% (P < 0.10) and 63.1% (P < 0.01), respectively. In the second trial, the germicide was diluted one part concentrate to three parts distilled water and tested using the same protocol. Efficacies were 67.8% (P < 0.001) and 77.2% (P < 0.001) against Staphylococcus aureus and Streptococcus agalactiae , respectively.